Ignite Creation Date:
2024-05-06 @ 12:51 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03863223
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-23
First Post:
2019-03-01
Brief Title:
A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-01
First Submit QC Date:
March 3 2019
Study First Post Date:
2019-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-21
Last Update Post Date:
2022-11-23
Last Update Post Date Type:
ACTUAL